Effect of cytosine arabinoside on nuclear labelling of leukaemic myeloblasts with tritiated thymidine triphosphate.
D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000378:metabolism; D002467:Cell Nucleus / Q000187:drug effects; D003561:Cytarabine / Q000378:metabolism / Q000494:pharmacology*; D004261:DNA Replication / Q000187:drug effects; D004273:DNA, Neoplasm / Q000378:metabolism; D003845:Deoxycytosine Nucleotides / Q000378:metabolism; D005260:Female; D006801:Humans; D007553:Isotope Labeling; D007700:Kinetics; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013936:Thymidine / Q000378:metabolism; D013942:Thymine Nucleotides / Q000378:metabolism*
D004273:DNA, Neoplasm; D003845:Deoxycytosine Nucleotides; D013942:Thymine Nucleotides; D003561:Cytarabine; C024157:thymidine 5'-triphosphate; D013936:Thymidine